Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17(10):1225–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonney GK, Coldham C, Adam R, Kaiser G, Barroso E, Capussotti L, et al. Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; an international multi-center data analysis using LiverMetSurvey. J Surg Oncol. 2015;111(6):716–24.

Article  PubMed  Google Scholar 

Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729–41.

Article  PubMed  Google Scholar 

Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, et al. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol. 2021;6(11):933–46.

Article  PubMed  Google Scholar 

Jones RP, Malik HZ, Fenwick SW, Poston GJ. Perioperative chemotherapy for resectable colorectal liver metastases: where now? Eur J Surg Oncol. 2013;39(8):807–11.

Article  CAS  PubMed  Google Scholar 

Narita M, Oussoultzoglou E, Bachellier P, Jaeck D, Uemoto S. Post-hepatectomy liver failure in patients with colorectal liver metastases. Surg Today. 2015;45(10):1218–26.

Article  CAS  PubMed  Google Scholar 

Sadahiro S, Suzuki T, Tanaka A, Okada K, Kamata H, Koisumi J. Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer. Surg Today. 2013;43(10):1088–94.

Article  CAS  PubMed  Google Scholar 

Okuno M, Hatano E, Kasai Y, Nishio T, Seo S, Taura K, et al. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases. Surg Today. 2016;46(6):721–8.

Article  PubMed  Google Scholar 

Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M, et al. Adjuvant Oral Uracil-Tegafur with Leucovorin for colorectal cancer liver metastases: a randomized controlled trial. PLoS ONE. 2016;11(9):e0162400.

Article  PubMed  PubMed Central  Google Scholar 

Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789–99.

Article  CAS  PubMed  Google Scholar 

Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007–16 (Mar 22;).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–15.

Article  CAS  PubMed  Google Scholar 

Hirokawa F, Asakuma M, Komeda K, Shimizu T, Inoue Y, Kagota S, et al. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer? Surg Today. 2019;49(1):82–9.

Article  CAS  PubMed  Google Scholar 

Kobayashi K, Ono Y, Kitano Y, Oba A, Sato T, Ito H, et al. Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable colorectal liver metastases stratified by tumor number and size: potentially valuable biologic markers for preoperative treatment. Ann Surg Oncol. 2023;30(12):7338–47.

Article  PubMed  Google Scholar 

Beppu T, Yamamura K, Imai K, Hayashi H, Miyamoto Y. Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases. J Surg Oncol. 2024;129(5):893–900.

Article  PubMed  Google Scholar 

Kitano Y, Hayashi H, Matsumoto T, Kinoshita S, Sato H, Shiraishi Y, et al. Borderline resectable for colorectal liver metastases: present status and future perspective. World J Gastrointest Surg. 2021;13(8):756–63 (Aug 27;).

Article  PubMed  PubMed Central  Google Scholar 

Vauthey J-N. Colorectal liver metastases: treat effectively up front and consider the borderline resectable. J Clin Oncol. 2007;25(29):4524–5.

Article  PubMed  Google Scholar 

Allard M-A, Adam R. Patient with unresectable colorectal liver metastases and asymptomatic primary tumor: end of the debate! Hepatobiliary Surg Nutr. 2022;11(3):412–4.

Article  PubMed  PubMed Central  Google Scholar 

Ychou M, Rivoire M, Thezenas S, Guimbaud R, Ghiringhelli F, Mercier-Blas A, et al. Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial. Br J Cancer. 2022;126(9):1264–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240(4):644–57.

Article  PubMed  PubMed Central  Google Scholar 

Adam R, Wicherts DA, de Haas RJ, Ciacio O, Lévi F, Paule B, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 2009;27(11):1829–35.

Article  PubMed  Google Scholar 

Kobayashi K, Inoue Y, Kitano Y, Sato S, Oba A, Ono Y, et al. Optimizing the selection of technically unresectable colorectal liver metastases. Surgery. 2023;173(2):442–9.

Article  PubMed  Google Scholar 

Matsumura M, Hasegawa K, Oba M, Yamaguchi K, Uetake H, Yoshino T, et al. A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study. Langenbecks Arch Surg. 2022;407(4):1345–56.

Article  PubMed  Google Scholar 

Watanabe G, Mise Y, Oba M, Saiura A, Inoue Y, Takahashi Y, et al. A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: nexto-mt trial. HPB. 2022;24(8):1245–51.

Article  PubMed  Google Scholar 

Kitano Y, Ono Y, Kobayashi K, Oba A, Sato T, Ito H, et al. Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study. HPB. 2023. https://doi.org/10.1016/j.hpb.2023.10.015.

Article  PubMed  Google Scholar 

Ichida H, Mise Y, Ito H, Ishizawa T, Inoue Y, Takahashi Y, et al. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. World J Surg Oncol. 2019;17(1):100.

Article  PubMed  PubMed Central  Google Scholar 

Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The tumor burden score: a new, “metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267(1):132.

Article  PubMed  Google Scholar 

Kawakatsu S, Mise Y, Hiratsuka M, Inoue Y, Ito H, Takahashi Y, et al. Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases. J Surg Oncol. 2020;122(3):523–8.

Article  PubMed  Google Scholar 

Ichinose J, Hashimoto K, Matsuura Y, Nakao M, Akiyoshi T, Fukunaga Y, et al. Optimal timing for lung metastasectomy in patients with colorectal cancer. Interact Cardiovasc Thorac Surg. 2022. https://doi.org/10.1093/icvts/ivac224.

Article  PubMed  PubMed Central  Google Scholar 

Saiura A, Yamamoto J, Koga R, Takahashi Y, Takahashi M, Inoue Y, et al. Favorable outcome after repeat resection for colorectal liver metastases. Ann Surg Oncol. 2014;21(13):4293–9.

Article  PubMed  Google Scholar 

Oba M, Hasegawa K, Shindoh J, Yamashita S, Sakamoto Y, Makuuchi M, et al. Survival benefit of repeat re